T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation

Clinical trial NCT05471661 · COMPLETED

Trial details

NCT number: NCT05471661
Sponsor: George Papanicolaou Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Opportunistic Fungal Infection Opportunistic Viral Infection Bone Marrow Transplant Infection

Start date: 2021-05-22
Primary completion: 2024-05-05
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.